University of Bremen Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2010
NCT01164059
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Dept. of Statistics and Medical Biometry, University of Bremen | Prof. Dr. Dr. Ursula Mirastschijski | University of Bremen

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Connective Tissue Diseases (Phase 1)

Schizophrenia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 8